A detailed history of Jane Street Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 7,305,094 shares of PFE stock, worth $209 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
7,305,094
Previous 8,678,244 15.82%
Holding current value
$209 Million
Previous $250 Million 18.86%
% of portfolio
0.28%
Previous 0.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $35.6 Million - $40.8 Million
-1,373,150 Reduced 15.82%
7,305,094 $203 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $139 Million - $181 Million
5,334,923 Added 159.57%
8,678,244 $250 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $37.8 Million - $44.2 Million
1,178,587 Added 54.44%
3,343,321 $111 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $796,120 - $921,093
-22,041 Reduced 1.01%
2,164,734 $79.4 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $30.8 Million - $40.1 Million
782,183 Added 55.69%
2,186,775 $89.2 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $41.1 Million - $53.7 Million
-984,951 Reduced 41.22%
1,404,592 $72 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $63.4 Million - $77.4 Million
1,448,139 Added 153.83%
2,389,543 $105 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $63.4 Million - $77.4 Million
1,448,139 Added 153.83%
2,389,543 $105 Million
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $54.6 Million - $64.8 Million
-1,173,799 Reduced 55.49%
941,404 $49.4 Million
Q1 2022

May 17, 2022

SELL
$45.75 - $56.69 $52.8 Million - $65.5 Million
-1,154,696 Reduced 35.31%
2,115,203 $110 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $67.8 Million - $101 Million
1,641,220 Added 100.77%
3,269,899 $193 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $11.8 Million - $15.1 Million
-299,682 Reduced 15.54%
1,628,679 $70.1 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $3.33 Million - $3.77 Million
92,768 Added 5.05%
1,928,361 $75.5 Million
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $16.4 Million - $18.4 Million
488,414 Added 36.25%
1,835,593 $66.5 Million
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $10 Million - $12.7 Million
299,283 Added 28.56%
1,347,179 $49.6 Million
Q3 2020

Nov 17, 2020

BUY
$31.75 - $37.25 $13.3 Million - $15.6 Million
420,043 Added 66.9%
1,047,896 $38.5 Million
Q2 2020

Aug 17, 2020

SELL
$30.12 - $36.54 $12.6 Million - $15.3 Million
-419,059 Reduced 40.03%
627,853 $20.5 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $7.01 Million - $10 Million
-259,338 Reduced 19.85%
1,046,912 $34.2 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $7.85 Million - $8.91 Million
-238,434 Reduced 15.44%
1,306,250 $51.2 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $35.5 Million - $46.1 Million
1,093,108 Added 242.07%
1,544,684 $55.5 Million
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $3.34 Million - $3.75 Million
90,372 Added 25.02%
451,576 $19.6 Million
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $1.28 Million - $1.41 Million
34,176 Added 10.45%
361,204 $15.3 Million
Q4 2018

Feb 15, 2019

BUY
$38.47 - $43.86 $11.1 Million - $12.6 Million
288,013 Added 738.21%
327,028 $14.3 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $5.91 Million - $7.17 Million
-171,381 Reduced 81.46%
39,015 $1.72 Million
Q2 2018

Aug 15, 2018

BUY
$32.98 - $35.16 $4.41 Million - $4.7 Million
133,785 Added 174.63%
210,396 $7.63 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.34 Million - $1.55 Million
41,871 Added 120.53%
76,611 $2.72 Million
Q4 2017

Feb 15, 2018

SELL
$33.26 - $35.29 $5.18 Million - $5.49 Million
-155,630 Reduced 81.75%
34,740 $1.26 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $5.9 Million - $6.5 Million
190,370
190,370 $6.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.